-8.6%
SNPS vs GSK
-10.9%
+2.3%
-30.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.4% | -1.9% | -3.5% | -5.8% |
| 7D | -11.0% | -1.8% | -9.2% | -11.3% |
| 30D | -1.7% | -2.2% | +0.4% | -2.0% |
| 3M | -20.4% | -1.8% | -18.5% | -20.2% |
| 6M | -8.6% | -10.6% | +2.0% | -9.5% |
| All | -8.6% | -10.9% | +2.3% | -9.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling